Pharmakonzerne vernachlässigen Medizin für die Ärmsten
Anja Ettel of Die Welt covers the latest results of the Access to Medicine Index. The article focuses on the handful of companies carrying out the majority of urgently needed R&D projects. She also highlights the performances of German companies in scope of the Index included Merck KGaA and Bayer.